Ventas Issues Business Update, Raises 2025 Normalized FFO Guidance

29.05.25 18:59 Uhr

Werte in diesem Artikel
Aktien

56,44 EUR -0,72 EUR -1,26%

Indizes

5.861,8 PKT -50,4 PKT -0,85%

Ventas, Inc. VTR recently provided an business update that highlights delivering profitable organic growth in the senior housing. This healthcare REIT also raised its normalized funds from operations (FFO) per share guidance for 2025.The fundamentals of senior housing continue to be healthy while entering the key selling season, driven by the record growing population aged 80 and above. The key selling season is underway, with projected spot occupancy growth ranging from +30 basis points (bps) to +50 bps sequentially from March 31, 2025, to May 31, 2025.Ventas’s 2025 Senior Housing Operating Portfolio (SHOP) segment's same-store cash net operating income (NOI) is anticipated to be between 12% to 16%, compared to the prior range of 11% to 16%. It expects SHOP same-store cash NOI year-over-year growth in second half of 2025 to be higher than the first half of 2025, due to timing and slope of key selling season.The company projected May quarter-to-date same-store average occupancy growth of +230 bps year over year. It also projected May year-to-date same-store average occupancy growth of approximately 270 bps.2025 Normalized FFO Guidance RaiseVentas expects 2025 normalized FFO per share in the range of $3.36-$3.46, revised from $3.35-$3.46 stated earlier. The 2025 normalized FFO per share represents approximately 7% year-over-year growth at the midpoint of the guidance range, led by SHOP. The Zacks Consensus Estimate of $3.44 per share stands within the given range.VTR: In a SnapshotVentas’ diverse portfolio of healthcare real estate assets in the key markets of the United States and the U.K. is well-poised to capitalize on the favorable industry fundamentals. The SHOP is likely to benefit from the aging population and the rising healthcare expenditures by senior citizens. The outpatient medical portfolio is expected to gain from the favorable outpatient visit trends. Ventas’ accretive investments to expand its research portfolio also look promising.Over the past six months, shares of this Zacks Rank #3 (Hold) company have gained 5% against the industry's decline of 5.3%. Image Source: Zacks Investment Research Stocks to ConsiderSome better-ranked stocks from the broader REIT sector are VICI Properties VICI and W.P. Carey WPC, each currently carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.The Zacks Consensus Estimate for VICI’s 2025 FFO per share has moved one cent northward to $2.34 over the past month.The consensus estimate for WPC’s 2025 FFO per share has been revised upward by 1% to $4.88 over the past month.Note: Anything related to earnings presented in this write-up represents FFO, a widely used metric to gauge the performance of REITs.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ventas, Inc. (VTR): Free Stock Analysis Report W.P. Carey Inc. (WPC): Free Stock Analysis Report VICI Properties Inc. (VICI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Ventas und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Ventas

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ventas

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Ventas Inc.

Wer­bung

Analysen zu Ventas Inc.

DatumRatingAnalyst
03.09.2019Ventas Equal WeightBarclays Capital
04.05.2018Ventas Market PerformBMO Capital Markets
22.03.2017Ventas HoldSunTrust
21.11.2016Ventas NeutralMizuho
13.07.2016Ventas HoldArgus Research Company
DatumRatingAnalyst
04.05.2018Ventas Market PerformBMO Capital Markets
06.07.2016Ventas BuyMizuho
05.04.2016Ventas BuyMizuho
03.03.2016Ventas BuyMizuho
15.01.2016Ventas Market PerformBMO Capital Markets
DatumRatingAnalyst
03.09.2019Ventas Equal WeightBarclays Capital
22.03.2017Ventas HoldSunTrust
21.11.2016Ventas NeutralMizuho
13.07.2016Ventas HoldArgus Research Company
02.05.2016Ventas Equal WeightBarclays Capital
DatumRatingAnalyst
24.05.2010Ventas "underperform"Robert W. Baird & Co. Incorporated

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ventas Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen